|
|
 |
|
Research
Publications |
“Treatment outcome and outcome associations in children with pervasive developmental disorders treated with serotonin reuptake inhibitors: a chart review.”
C. A. Henry, MD, R. Steingard, MD, J. Venter, MD, J. Guptill, MD, E. Halpern, PhD, M. Bauman, MD.
J Child Adolesc Psychopharm. 2006 Feb-Apr;16(1-2):187-95.
|
|
|
| |
“Insight in psychosis: a systematic review of treatment interventions.”
C. A. Henry, MD, S.N. Ghaemi, MD.
Psychopathology. 2004 Jul-Aug;37(4):194-9.
|
|
|
|
|
| |
“Chart review of long-term outcome with divalproex in children and adolescents With bipolar disorder.”
C. A. Henry, MD, L. Zamvil, MD, C. Lam, MD, K.J. Rosenquist, BS, S.N. Ghaemi, MD.
J Child Adolesc Psychopharm. 2003 Winter;13(4):523-9. |
|
|
|
|
|
|
|
|
|
| Abstracts |
“Insight, physical dishevelment, and theory of mind.”
C. Henry, MD, L. Seidman, PhD, D. Liriano, PhD, K. Rosenquist, BA, D. Hsu, BA, S. N. Ghaemi, MD, R. Steingard, MD.
2003 American Psychiatric Association Annual Meeting, San Francisco, California.
|
|
| |
|
| |
“Chart review of long-term outcome with divalproex in children and adolescents With bipolar disorder.”
C. Henry, MD, L. Zamvil, MD, C. Lam, MD, K.J. Rosenquist, BS, S.N. Ghaemi, MD.
2002 American |
| |
|
|
"1.8 year outcome with risperidone in treatment of children.;"
C. Lam, MD, K.J. Rosenquist, BS, C. Henry, MD, S.N. Ghaemi, MD.
2002 American Psychiatric Association Annual Meeting, Philadelphia, Pennsylvania. |
|
|
| Research |
“A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study with Three Fixed Doses of Aripiprazole in the Treatment of Children and Adolescents with Autistic Disorder.”
C. Henry, MD – Site Principal Investigator
|
| |
| |
|
|
|
| |
“A 52-Week, Open-label, Multicenter Study of the Safety and Tolerability of Aripiprazole Flexible Dosed in the Treatment of Children and Adolescents with Autistic Disorder.”
C. Henry, MD – Site Principal Investigator
|
| |
|
|
|
|
|
|
|
|
